Liu Xin, Liu Kaiqing, Hu Lifu, Liu Zixiao, Liu Xinhua, Wang Jiantao
Shenzhen Eye Hospital, Jinan University, Shenzhen Eye Institute, Shenzhen, China.
Shenzhen Luohu Hospital Group, The Third Affiliated Hospital of Shenzhen University, Shenzhen, China.
Heliyon. 2025 Jan 18;11(2):e42116. doi: 10.1016/j.heliyon.2025.e42116. eCollection 2025 Jan 30.
Loeys-Dietz syndrome (LDS) is a rare autosomal dominant disorder with extensive connective tissue involvement. The diagnosis of this disease is mainly based on clinical features combined with the detection of pathogenic gene mutations, mainly mutations in the transforming growth factor-beta (TGF-β) signaling pathway.
The molecular pathogenesis of a LDS syndrome proband and his family members was analyzed using whole exome sequencing and validated using Sanger sequencing. Molecular dynamics simulations and in vitro cell experiments further analyzed the structural changes and functional abnormalities of the variation.
This study describes the case of a 6-month-old infant diagnosed with LDS with typical craniofacial abnormalities, developmental delay, and a dilated aortic sinus (19 mm; Z-score 3.5). Genetic analysis showed the patient carried a novel de novo TGF-β receptor 2 (TGFBR2) mutation (NM_003242: c.1005_1007delGTA (p.Glu335_Tyr336delinsAsp)). Molecular dynamics simulation showed that the TGFBR2 c.1005_1007delGTA mutation changed the protein conformation, making the protein conformation more stable. The p.Glu335_Tyr336delinsAsp mutation significantly reduced TGF-β-induced gene transcription and phosphorylation of SMAD Family Member 2 (SMAD2) .
Our comprehensive genetic analysis suggested that the p.Glu335_Tyr336delinsAsp variant of TGFBR2 caused aberrant TGF-β signaling and contributed to LDS in the patient.
洛伊斯-迪茨综合征(LDS)是一种罕见的常染色体显性疾病,伴有广泛的结缔组织受累。该疾病的诊断主要基于临床特征并结合致病基因突变的检测,主要是转化生长因子-β(TGF-β)信号通路中的突变。
使用全外显子组测序分析一名LDS综合征先证者及其家庭成员的分子发病机制,并使用桑格测序进行验证。分子动力学模拟和体外细胞实验进一步分析了该变异的结构变化和功能异常。
本研究描述了一名6个月大婴儿被诊断为LDS的病例,该婴儿具有典型的颅面畸形、发育迟缓以及扩张的主动脉窦(19毫米;Z评分3.5)。基因分析显示患者携带一种新的转化生长因子-β受体2(TGFBR2)的新生突变(NM_003242: c.1005_1007delGTA (p.Glu335_Tyr336delinsAsp))。分子动力学模拟表明,TGFBR2 c.1005_1007delGTA突变改变了蛋白质构象,使蛋白质构象更稳定。p.Glu335_Tyr336delinsAsp突变显著降低了TGF-β诱导的基因转录以及SMAD家族成员2(SMAD2)的磷酸化。
我们的综合基因分析表明,TGFBR2的p.Glu335_Tyr336delinsAsp变异导致了异常的TGF-β信号传导,并促成了该患者的LDS。